Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to 10.15%.

  • Bioharvest Sciences' EBITDA Margin rose 220000.0% to 10.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.77%, marking a year-over-year increase of 823700.0%. This contributed to the annual value of 27.75% for FY2024, which is 509000.0% up from last year.
  • Per Bioharvest Sciences' latest filing, its EBITDA Margin stood at 10.15% for Q3 2025, which was up 220000.0% from 21.32% recorded in Q2 2025.
  • Bioharvest Sciences' EBITDA Margin's 5-year high stood at 104.55% during Q2 2023, with a 5-year trough of 384.58% in Q4 2023.
  • For the 3-year period, Bioharvest Sciences' EBITDA Margin averaged around 38.28%, with its median value being 22.52% (2024).
  • Over the last 5 years, Bioharvest Sciences' EBITDA Margin had its largest YoY gain of 3614000bps in 2024, and its largest YoY loss of -1340100bps in 2024.
  • Bioharvest Sciences' EBITDA Margin (Quarter) stood at 384.58% in 2023, then surged by 94bps to 23.18% in 2024, then soared by 56bps to 10.15% in 2025.
  • Its last three reported values are 10.15% in Q3 2025, 21.32% for Q2 2025, and 21.87% during Q1 2025.